Olga Sánchez- Maroto Carrizo I'm a graduate in Biology at the Universitat Autònoma de Barcelona. Since 2001 I have been linked to the world of clinical research in different positions. I have worked both in the public and private sphere. I have participated in different types of clinical research in various indications. Institutions of which they are part Clinical Research Development Directorate Vall Hebron Institut de Recerca LinkedIn Twitter Email Olga Sánchez- Maroto Carrizo LinkedIn Twitter Email Institutions of which they are part Clinical Research Development Directorate Vall Hebron Institut de Recerca I'm a graduate in Biology at the Universitat Autònoma de Barcelona. Since 2001 I have been linked to the world of clinical research in different positions. I have worked both in the public and private sphere. I have participated in different types of clinical research in various indications.
EDUCATION • Universitat de Barcelona, Master in Experimental Bioscience, 2001 • Universitat Autònoma de Barcelona, Bachelor in Biology. Microbiology specialist, 2000 ADDITIONAL RELEVANT TRAININGS • Programa de Alta Dirección en Instituciones Sanitarias. IESE. 2021. • Course on Human Rights and Bioethics in Clínics and Investigation. Universidad Nacional de Educación a Distancia. 2020 • Course on Biomedicine and Law Universidad Nacional de Educación a Distancia. 2019 • Project Management in Clinical Research. CESIF. 2018 • Basic Statisctics for Clinical Research. VHIR. March 2017 • Health and Law. Universidad Nacional de Educación a Distancia. 2008 PROFESSIONAL EXPERIENCE Period: April 2014 – Present Position: Unit Head Academic Research Organization Organization: VHIR – Institut de Recerca Vall d’Hebron Period: March 2013 – April 2014 Position: Sr. Associate Clinical Operations Manager Organization: Amgen Period: December 2012 – February 2013 Position: Sr. Associate Clinical Operations Manager Organization: Pharmanet i3 (in exclusive for Amgen) Period: January 2009 - July 2012 Position: Clinical Research Manager Organization: RPS Research Iberica, S.L.U, Period: September 2005 – January 2009 Position: Clinical Research Manager Organization: Infociencia Clinical Research, Period: November 2001 – September 2005 Position: Clinical Research Associated Organization: Infociencia Clinical Research
Research lines ARO IP: Olga Sánchez- Maroto Carrizo Projects Plataforma de soporte para la Investigación Clínica IP: Inmaculada Fuentes Camps Collaborators: Antonio Moreno Galdó, Rafael Simó Canonge, Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Joan Genescà Ferrer, Gemma Vona Giralt, Paula Isabel Roldan Caballero Funding agency: Instituto de Salud Carlos III Funding: 274920 Reference: PT23/00062 Duration: 01/01/2024 - 31/12/2026 QUSTom - Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging. IP: Ana Maria Rodriguez Arana Collaborators: Olga Sánchez- Maroto Carrizo, Almudena Maceda Garcia, Gladys Liliana Lino Villanueva, Paula Isabel Roldan Caballero, Ester Serrano I Porras Funding agency: EUROPEAN COMMISSION Funding: 400871.25 Reference: QUSTOM_HE-EIC-PATHFINDEROPEN2021 Duration: 01/04/2022 - 30/09/2024 RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 IP: Pere Soler Palacín Collaborators: Miriam Gonzalez Amores, RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2, Ariadna Martín Balcells, Amaia Latasa Arrazubi, Noemí Giménez Sanz, Olga Sánchez- Maroto Carrizo Funding agency: EUROPEAN COMMISSION Funding: 475000 Reference: RBDCOV_HE-HLTH-CORONA2021 Duration: 01/12/2021 - 31/08/2025 Plataforma ISCIII de soporte para la Investigación Clínica IP: Inmaculada Fuentes Camps Collaborators: Gemma Vona Giralt, Antonio Moreno Galdó, Rafael Simó Canonge, Núria Pérez Picazo, Plataforma ISCIII de soporte para la Investigación Clínica , Ariadna Martín Balcells, Olga Sánchez- Maroto Carrizo, Joan Genescà Ferrer, Paula Isabel Roldan Caballero Funding agency: Instituto de Salud Carlos III Funding: 315150 Reference: PT20/00078 Duration: 01/01/2021 - 31/12/2024 Pagination Current page 1 Page 2 Page 3 Page 4 Next page › Last page »
